Literature DB >> 6708454

Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus.

R Janssen, F Gonzalez-Scarano, N Nathanson.   

Abstract

To analyze mechanisms of virulence in the California serogroup bunyaviruses, the virulent La Crosse/original (LAC/original) strain was compared with the avirulent Tahyna/181-57 strain. In suckling mice, both viruses were lethal upon intracerebral injection but differed markedly in their neuroinvasiveness following subcutaneous injection; 20 and 20,000 plaque-forming units, respectively, were equivalent to 1 subcutaneous LD50. The sequential course of infection was followed after subcutaneous injection of 700 plaque-forming units; LAC/original replicated in striated muscle, caused a high titer plasma viremia, invaded the central nervous system, and killed all mice; the same dose of avirulent Tahyna/181-57 failed to replicate in extraneural tissues, did not invade the central nervous system, and caused no apparent illness. Immunofluorescent examination of peripheral and central nervous system tissues showed the same distinctions between virulent and avirulent viruses and pinpointed striated muscle as the major extraneural target of virulent LAC/original virus. Paradoxically, after intracerebral injection of suckling or adult mice, Tahyna/181-57 virus killed more quickly than LAC/original. This difference was correlated with replication differences; Tahyna/181-57 multiplied marginally faster in the brain than did LAC/original virus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708454

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  34 in total

1.  Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.

Authors:  M J Endres; C Griot; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching.

Authors:  Kaycie C Hopkins; Laura M McLane; Tariq Maqbool; Debasis Panda; Beth Gordesky-Gold; Sara Cherry
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

3.  Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes.

Authors:  Bradley S Hollidge; Natalia B Nedelsky; Mary-Virginia Salzano; Jonathan W Fraser; Francisco González-Scarano; Samantha S Soldan
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.

Authors:  A Bridgen; F Weber; J K Fazakerley; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

5.  Virulence of La Crosse virus is under polygenic control.

Authors:  R S Janssen; N Nathanson; M J Endres; F Gonzalez-Scarano
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

6.  Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide.

Authors:  Matthew L Plassmeyer; Samantha S Soldan; Karen M Stachelek; Susan M Roth; Julio Martín-García; Francisco González-Scarano
Journal:  Virology       Date:  2006-10-05       Impact factor: 3.616

7.  Growth of a neuroinvasive strain of bluetongue virus in suckling mice.

Authors:  M A Carr; A W Brewer; B I Osburn
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Typing of LaCrosse, snowshoe hare, and Tahyna viruses by analyses of single-strand conformation polymorphisms of the small RNA segments.

Authors:  W C Black; D L Vanlandingham; W P Sweeney; L P Wasieloski; C H Calisher; B J Beaty
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.

Authors:  C Griot; A Pekosz; D Lukac; S S Scherer; K Stillmock; D Schmeidler; M J Endres; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.